News

Sheffield cystic fibrosis research team win award at international conference
17th June 2016

Sheffield cystic fibrosis research team win award at international conference

Dr Hui Hoo, who is funded by an NIHR Research Fellowship, has won a poster prize at the International European Cystic Fibrosis Conference. This important award reflects the recognition that this work represents a way to shift CF care from expensi...

Read More

International Clinical Trials Day
16th May 2016

International Clinical Trials Day

International Clinical Trials Day commemorates the day in 1747 that James Lind started his trial on the deadly disease scurvy. The trial consisted of 12 sailors with scurvy, given a variety of dietary supplements from cider to oranges and lemons. ...

Read More

New study: Tocilizumab in the Treatment of Pulmonary Arterial Hypertension
6th May 2016

New study: Tocilizumab in the Treatment of Pulmonary Arterial Hypertension

New study: A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension Inflammation and autoimmunity have an important role in Pulmonary Hypertension, a serious condition characterised by raised blood pressur...

Read More

New study: Assessing Idiopathic Lung Fibrosis with MR Imaging
1st March 2016

New study: Assessing Idiopathic Lung Fibrosis with MR Imaging

Idiopathic pulmonary fibrosis (IPF) is a lung disease with no known cure, in spite of recent antifibrotic treatment advances. Lung magnetic resonance imaging (MRI) has shown early promise as a tool in helping to understand microstructural, functio...

Read More

SOMOSA: Study of Mechanisms of Action of Omalizumab in Severe Asthma.
1st March 2016

SOMOSA: Study of Mechanisms of Action of Omalizumab in Severe Asthma.

A study led by the University of Southampton has been initiated involving the Sheffield Severe Asthma service, Principal Investigator Prof Ian Sabroe, the Respiratory Physiology department and the Clinical Research Facility. In this study we are r...

Read More

Development of an intervention to support Adherence to treatment in adults with Cystic Fibrosis
1st March 2016

Development of an intervention to support Adherence to treatment in adults with Cystic Fibrosis

ACTiF is a 5 year research programme funded by the National Institute for Health Research, led by a Sheffield team at the STH Adult Cystic Fibrosis Centre and the University of Sheffield School of Health and Related Research (ScHARR). The programm...

Read More

The Big Walk: 286 miles in 15 days raising funds for Lung Disease research.
14th July 2015

The Big Walk: 286 miles in 15 days raising funds for Lung Disease research.

A team from the University of Sheffield are taking part in a special fundraising walk covering 286 miles in 15 days. The walk along the full Pennine Way will take place between 2nd and 17th September 2015 to raise funds for Lung Disease resea...

Read More

Prestigious NIHR Programme Grant awarded to Sheffield cystic fibrosis research team
25th November 2014

Prestigious NIHR Programme Grant awarded to Sheffield cystic fibrosis research team

A UK-wide consortium of Cystic Fibrosis clinicians and researchers, led by Dr Martin Wildman of Sheffield Teaching Hospitals and Professor Alicia O’Cathain at the School of Health and Related Research (ScHARR, University of Sheffield) and th...

Read More

NIHR HTA award to Sheffield for research into lung disease exercise rehabilitation programme
26th September 2014

NIHR HTA award to Sheffield for research into lung disease exercise rehabilitation programme

A research team led by Dr Rodney Hughes of the Academic Directorate of Respiratory Medicine at Sheffield Teaching Hospitals, in collaboration with the University of Sheffield Clinical Trials Research Unit and Aintree Hospital in Liverpool, has bee...

Read More